MediciNova (MNOV) Expected to Announce Earnings on Thursday

MediciNova (NASDAQ:MNOV) will likely be posting its quarterly earnings results before the market opens on Thursday, February 20th. Analysts expect MediciNova to post earnings of ($0.06) per share for the quarter.

MediciNova Price Performance

Shares of NASDAQ:MNOV opened at $1.96 on Wednesday. The company has a market capitalization of $96.13 million, a price-to-earnings ratio of -9.33 and a beta of 0.82. The firm’s 50 day simple moving average is $2.00 and its 200 day simple moving average is $1.83. MediciNova has a fifty-two week low of $1.12 and a fifty-two week high of $2.55.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. D. Boral Capital assumed coverage on shares of MediciNova in a research report on Monday, December 2nd. They issued a “buy” rating and a $9.00 price target on the stock. StockNews.com assumed coverage on shares of MediciNova in a research report on Tuesday, February 11th. They issued a “hold” rating on the stock.

About MediciNova

MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID.